EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model

Shashwat Tripathi, Hinda Najem, Lisa Hurley, Ruochen Du, Crismita Dmello, Heba Ali, Kathleen McCortney, Karl J Habashy, Peng Zhang, Craig M Horbinski, Lara Leoni, Ryan J Avery und 11 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci198843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Shashwat Tripathi und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery. Hauptthemen laut MEDLINE: Membrane Proteins, Blood-Brain Barrier, Brain Neoplasms, Glioma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiation therapy (RT) is the standard of care for glioblastoma but is not curative. Triggering the cGAS/stimulator of interferon genes (STING) pathway with potent agonists, such as 8803, exerts activity across high-grade glioma preclinical models. To determine if the combination of 8803 with RT warrants consideration in the up-front treatment setting and to clarify the underlying mechanisms of therapeutic activity, C57BL/6J mice harboring intracerebral CT-2A or QPP8v gliomas were treated with RT, intratumoral 8803, or both. The treatment with the combination resulted in 80% long-term survival in the CT-2A model but not in the radiation-resistant QPP8v model. This therapeutic effect was maintained in Sting –/– CT-2A cells, highlighting the direct role of the immune system in mediating the survival benefit. Single-cell RNA-Seq identified increased nitric oxide synthase 2 ( Nos2 ) in inflammatory tumor-associated macrophages; however, the therapeutic effect was maintained in Nos2 –/– mice. Additionally, 8803 reprogrammed the blood-brain barrier (BBB) by altering the Pecam and Cd147 pathways in endothelial cells; intracranial injection of 8803 induced bihemispheric BBB opening for up to 24 hours. Sting activation was visualized longitudinally using 3’-deoxy-3’-[ 18 F]-fluorothymidine ([ 18 F]-FLT) PET, which peaked 72–96 hours after 8803 administration. In summary, 8803 combined with RT triggers distinctive antiglioma immune reactivity, facilitates BBB opening, and warrants consideration for up-front clinical trials in glioblastoma, where treatment effects can be monitored using [ 18 F]-FLT PET imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsBlood-Brain BarrierBrain NeoplasmsGliomaNeoplasm ProteinsNeoplasms, ExperimentalAnimalsSTING ProteinMiceMice, Inbred C57BLMice, KnockoutcGAS-STING Signaling PathwayHumansDisease Models, Animal

Stichwörter der Autor:innen

Brain cancerCancer immunotherapyImmunologyOncologyTherapeuticsVascular biology

Substanzen

STING ProteinSting1 protein, mouseMembrane ProteinsNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Neurological Surgery.
  • Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center.
  • Department of Radiology.
  • Department of Neurology, and.
  • Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California, San Francisco, San Francisco, California, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute

Zitieren

APA

Tripathi, S., Najem, H., Hurley, L., Du, R., Dmello, C., Ali, H., McCortney, K., Habashy, K. J., Zhang, P., Horbinski, C. M., Leoni, L., Avery, R. J., Lukas, R. V., Sita, T. L., Raleigh, D. R., Sachdev, S., Stupp, R., Lesniak, M. S., Ashley, D. M., …, & Heimberger, A. B. (2026). STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model. Journal of Clinical Investigation. https://doi.org/10.1172/jci198843

Vancouver

Tripathi S, Najem H, Hurley L, Du R, Dmello C, Ali H, et al. STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model. Journal of Clinical Investigation. 2026. doi:10.1172/jci198843

BibTeX
@article{Tripathi2026,
  author = {Tripathi, Shashwat and Najem, Hinda and Hurley, Lisa and Du, Ruochen and Dmello, Crismita and Ali, Heba and McCortney, Kathleen and Habashy, Karl J and Zhang, Peng and Horbinski, Craig M and Leoni, Lara and Avery, Ryan J and Lukas, Rimas V and Sita, Timothy L and Raleigh, David R and Sachdev, Sean and Stupp, Roger and Lesniak, Maciej S and Ashley, David M and Procissi, Daniele and Curran, Michael A and Balyasnikova, Irina and Heimberger, Amy B},
  title = {STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci198843}
}
Kostenlos starten →